| 8536164 |
Fused pyridine compounds as casein kinase inhibitors |
Ramalakshmi Yegna Chandrasekaran, Scot Richard Mente, Chakrapani Subramanyam, Travis T. Wager |
2013-09-17 |
| 8389743 |
Histamine-3 receptor antagonists |
Travis T. Wager, Ramalakshmi Yegna Chandrasekaran |
2013-03-05 |
| 8314139 |
Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereof |
Travis T. Wager |
2012-11-20 |
| 8178574 |
Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide |
Travis T. Wager |
2012-05-15 |
| 8158673 |
Histamine-3 receptor antagonists |
Travis T. Wager, Ramalakshmi Yegna Chandrasekaran |
2012-04-17 |
| 6664258 |
Spirocyclic dopamine receptor subtype ligands |
Anton Fliri |
2003-12-16 |
| 6552015 |
Azabicycloalkane derivatives and therapeutic uses thereof |
Anton Fliri, Randall J. Gallaschun |
2003-04-22 |
| 6521630 |
Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
Anton Fliri, Randall J. Gallaschun, John Ragan, Brian Patrick Jones |
2003-02-18 |
| 6372762 |
Substituted bicyclic derivatives for treating central nervous system disorders |
Anton Fliri |
2002-04-16 |
| 6046213 |
Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
Bertrand L. Chenard |
2000-04-04 |
| 5744483 |
Neuroprotective compounds |
Bertrand L. Chenard |
1998-04-28 |
| 5436255 |
Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
— |
1995-07-25 |
| 5356905 |
Neuroprotective 3-piperidino-4-hydroxychroman derivatives and analogs |
— |
1994-10-18 |
